[{"path":"index.html","id":"welcome","chapter":"Welcome","heading":"Welcome","text":"thesis plan…","code":""},{"path":"effect-heterogeneity.html","id":"effect-heterogeneity","chapter":"Effect heterogeneity","heading":"Effect heterogeneity","text":"","code":""},{"path":"effect-heterogeneity.html","id":"kent-et-al-bmj-2018","chapter":"Effect heterogeneity","heading":"Kent et al, BMJ, 2018","text":"LinkAustin Bradford Hill: RCTs determine better treatment average \nanswer practicing doctor’s question: “likely outcome\nparticular drug given patient”?Resut positive RCT evidence enrollees benefited\nintervention.Reichenbah suggested calibration narrowest reference class \nreliable statistics can compiled. quickly loses power (small sample \nthousands subgroups).need principled way prioritize characteristics. Model required \n.Link literature review.","code":""},{"path":"effect-heterogeneity.html","id":"iwashyna-et-al-american-journal-of-respiratory-and-critical-care-medicine.-2015","chapter":"Effect heterogeneity","heading":"Iwashyna et al, American Journal of Respiratory and Critical Care Medicine. 2015","text":"LinkGuyat et al: patient meets inclusion criteria violate \nexclusion criteria overall resutls RCT applicable.Surgery better average, however benfits higher risk\npatients. Lower risk patients harmed (see\nRCT\nRothwell, et al)","code":""},{"path":"effect-heterogeneity.html","id":"ioannidis-et-al-jce-1997","chapter":"Effect heterogeneity","heading":"Ioannidis et al, JCE, 1997","text":"LinkHeterogeneous population -> Heterogeneous risk -> small subgroups contribute \nmajority observed outcomes.Suggestion: Include graph demonstrating . Maybe use GUSTO-?","code":""},{"path":"effect-heterogeneity.html","id":"dahabreh-et-al-ije-2016","chapter":"Effect heterogeneity","heading":"Dahabreh et al, IJE, 2016","text":"LinkIndividual-level HTE unobservable. patient belongs one “immune”,\n“doomed”, “harmed” “saved”. Unkowable (fundamental problem causal\ninference).HTE scale-dependentSuggestion: Add plot constant RR variable ARR (include\ntreatment-related harms).HTE usually assessed relative scale (interaction) absolute scale\n(NNT) relevant one decision-making.risk heterogeneity present non-null treatment effect -> HTE \nscale. Risk magnification (Harell).","code":""}]
